These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26713063)
1. The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro. Lee JS; Kim YH; Park YM J Korean Med Sci; 2015 Dec; 30(12):1856-64. PubMed ID: 26713063 [TBL] [Abstract][Full Text] [Related]
2. Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components. Qu M; Wang Y; Yang L; Zhou Q Mol Vis; 2011; 17():3147-55. PubMed ID: 22171161 [TBL] [Abstract][Full Text] [Related]
3. Diclofenac protects cultured human corneal epithelial cells against hyperosmolarity and ameliorates corneal surface damage in a rat model of dry eye. Sawazaki R; Ishihara T; Usui S; Hayashi E; Tahara K; Hoshino T; Higuchi A; Nakamura S; Tsubota K; Mizushima T Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2547-56. PubMed ID: 24677100 [TBL] [Abstract][Full Text] [Related]
4. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Wang QW; Yao K; Xu W; Chen PQ; Shentu XC; Xie X; Weng Y; Zhang L; Jin CF; Wu W; Zhu YN; Yu YH Ophthalmologica; 2013; 229(4):187-94. PubMed ID: 23429038 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride]. He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage]. Chen S; Jiang Y; Yu C; Li Y Zhonghua Yan Ke Za Zhi; 2015 Jan; 51(1):45-50. PubMed ID: 25877710 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of topical pranoprofen and fluorometholone in cases with chronic allergic conjunctivitis. Li Z; Mu G; Chen W; Gao L; Jhanji V; Wang L Cornea; 2013 May; 32(5):579-82. PubMed ID: 23023407 [TBL] [Abstract][Full Text] [Related]
8. Effects of fluoroquinolone eye solutions without preservatives on human corneal epithelial cells in vitro. Oum BS; Kim NM; Lee JS; Park YM Ophthalmic Res; 2014; 51(4):216-23. PubMed ID: 24732570 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of pranoprofen combined with fluorometholone eye drops on postoperative reaction of corneal cross-linking. Pang X; Fan ZJ; Peng XJ; Jia HZ; Wu TF Eye Sci; 2012 Dec; 27(4):173-7. PubMed ID: 23225837 [TBL] [Abstract][Full Text] [Related]
10. [The clinical efficacy of 0.1% bromfenac sodium hydrate ophthalmic solution after excimer laser in situ keratomileusis]. Xu Y; Zhao X; Zhang FJ; Wang MM; Guo N; Zheng Y; Liu J; Zhang QL Zhonghua Yan Ke Za Zhi; 2013 Apr; 49(4):320-6. PubMed ID: 23900091 [TBL] [Abstract][Full Text] [Related]
11. Fixed-Combination Eye Drops Based on Fluorometholone Nanoparticles and Bromfenac/Levofloxacin Solution Improve Drug Corneal Penetration. Otake H; Goto R; Ogata F; Isaka T; Kawasaki N; Kobayakawa S; Matsunaga T; Nagai N Int J Nanomedicine; 2021; 16():5343-5356. PubMed ID: 34413642 [TBL] [Abstract][Full Text] [Related]
12. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery. Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells. Ayaki M; Yaguchi S; Iwasawa A; Koide R Clin Exp Ophthalmol; 2008 Aug; 36(6):553-9. PubMed ID: 18954319 [TBL] [Abstract][Full Text] [Related]
14. Cellular toxicity of calf blood extract on human corneal epithelial cells in vitro. Park YM; Kim SJ; Han YS; Lee JS Curr Eye Res; 2015 Jan; 40(1):66-71. PubMed ID: 24833044 [TBL] [Abstract][Full Text] [Related]
15. Dose dependent cytotoxicity of pranoprofen in cultured human corneal endothelial cells by inducing apoptosis. Li YH; Wen Q; Fan TJ; Ge Y; Yu MM; Sun LX; Zhao Y Drug Chem Toxicol; 2015 Jan; 38(1):16-21. PubMed ID: 24641202 [TBL] [Abstract][Full Text] [Related]
16. Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent. Jones J; Francis P Expert Opin Pharmacother; 2009 Oct; 10(14):2379-85. PubMed ID: 19735215 [TBL] [Abstract][Full Text] [Related]
17. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. Nagai N; Ito Y; Okamoto N; Shimomura Y Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350 [TBL] [Abstract][Full Text] [Related]
18. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. Asai T; Nakagami T; Mochizuki M; Hata N; Tsuchiya T; Hotta Y Cornea; 2006 Feb; 25(2):224-7. PubMed ID: 16371788 [TBL] [Abstract][Full Text] [Related]
19. Ocular safety comparison of non-steroidal anti-inflammatory eye drops used in pseudophakic cystoid macular edema prevention. Fernández-Ferreiro A; Santiago-Varela M; Gil-Martínez M; Parada TG; Pardo M; González-Barcia M; Piñeiro-Ces A; Rodríguez-Ares MT; Blanco-Mendez J; Lamas MJ; Otero-Espinar FJ Int J Pharm; 2015 Nov; 495(2):680-91. PubMed ID: 26423177 [TBL] [Abstract][Full Text] [Related]
20. Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery. Hoy SM Clin Drug Investig; 2015 Aug; 35(8):525-9. PubMed ID: 26177719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]